Embecta Corp Cash Flow Conversion Efficiency
Embecta Corp cash flow conversion efficiency. Based on the latest financial reports, Embecta Corp (EMBC) has a cash flow conversion efficiency ratio of -0.068x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($41.80 Million) by net assets ($-612.70 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Embecta Corp (2019–2025)
Cash flow conversion efficiency of Embecta Corp from 2019 to 2025. This chart illustrates how Embecta Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View EMBC live share price for real-time trading data and today's change.
Embecta Corp Cash Flow Conversion Ratio Explained
Embecta Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Embecta Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Embecta Corp ranked by their cash flow conversion efficiency. Also see how much is Embecta Corp worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Invesco Municipal Income Opportunities Closed Fund Class Common
NYSE:OIA
|
0.021x |
|
XiAn Typical Industries Co Ltd
SHG:600302
|
-0.036x |
|
NACL Industries Limited
NSE:NACLIND
|
-0.131x |
|
Marine Products Corporation
NYSE:MPX
|
0.077x |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
0.040x |
|
Long Yuan Construction Group Co Ltd
SHG:600491
|
0.027x |
|
Arvind SmartSpaces Limited
NSE:ARVSMART
|
0.150x |
|
ADF Foods Limited
NSE:ADFFOODS
|
0.056x |
Annual Cash Flow Conversion Efficiency for Embecta Corp (2019–2025)
The table below shows the annual cash flow conversion efficiency of Embecta Corp from 2019 to 2025. Review EMBC cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $-651.20 Million | $191.70 Million | -0.294x | -508.80% |
| 2024-09-30 | $-738.30 Million | $35.70 Million | -0.048x | +41.31% |
| 2023-09-30 | $-821.70 Million | $67.70 Million | -0.082x | +82.18% |
| 2022-09-30 | $-891.40 Million | $412.20 Million | -0.462x | -160.24% |
| 2021-09-30 | $594.00 Million | $456.00 Million | 0.768x | -11.91% |
| 2020-09-30 | $572.00 Million | $498.50 Million | 0.872x | +6.82% |
| 2019-09-30 | $619.00 Million | $505.00 Million | 0.816x | -- |
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors… Read more